TapewireFind a company

person · Reporting owner

Paterson Dan

Disclosed activity across 1 company

Tapewire entity
26167
SEC CIK
0001563202

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Verastem, Inc.VSTM · Entity 5242Director · President and CEOSeptember 30, 2026October 03, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Verastem, Inc.

Report date September 30, 2026 · Filed October 03, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect652,712 Ending reported balance After 2026-10-01 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-09-30 · Grant · Disposed 106,893 · Balance 696,833

F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved.

Row 2 · 2026-10-01 · Sale · Disposed 44,121 · Balance 652,712

F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs.

Filing footnotes · ownership attribution and instrument terms

F1: The reported securities were subject to a performance restricted stock units ("RSU") award that was granted on January 21, 2026. 106,893 RSUs vested on September 30, 2026, upon the Issuer's Compensation Committee of the board of directors determining the performance criteria related to certain clinical development goals had been achieved.

F2: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of RSUs.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (right to buy) · Derivative 144,137 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 13

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,137

Underlying: Common Stock · 144,137 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 30,708 Not disclosed Strike: $28.32 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 12

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,708 shares

Expires 2031-01-04

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F13 · derivative.exercise_date: The canceled option was granted on December 15, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 33,962 Not disclosed Strike: $26.40 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 11

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,962 shares

Expires 2030-12-18

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F12 · derivative.exercise_date: The canceled option was granted on December 18, 2020 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 12,500 Not disclosed Strike: $16.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 10

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2029-12-13

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F11 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 16,666 Not disclosed Strike: $16.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 9

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,666 shares

Expires 2029-12-13

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F10 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and vesting as to 12.5% of the shares underlying the option at the end of each successive three-month period following the first anniversary of grant date until the second anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 20,832 Not disclosed Strike: $21.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 8

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,832 shares

Expires 2029-06-21

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F9 · derivative.exercise_date: The canceled option was granted on June 21, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 12.5% of the shares underlying the option on each successive three month period after such date until the second anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 6,250 Not disclosed Strike: $42.12 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 7

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2029-01-03

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F8 · derivative.exercise_date: The canceled option was granted on January 3, 2019 and provided for vesting as to 25% of the shares underlying the option on January 1, 2020 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2023.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 3,750 Not disclosed Strike: $35.64 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 6

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,750 shares

Expires 2028-01-05

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F7 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting based on the achievement of certain performance milestones which were met by June 30, 2018 and by March 31, 2019.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 6,249 Not disclosed Strike: $35.64 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 5

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,249 shares

Expires 2028-01-05

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F6 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting as to 25% of the shares underlying the option on January 1, 2019 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2022.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 8,333 Not disclosed Strike: $16.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 4

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,333 shares

Expires 2026-06-13

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F5 · derivative.exercise_date: The canceled option was granted on June 14, 2016 and provided for vesting as to 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in June 2017, and vesting as to the remaining 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in September 2017.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 5,500 Not disclosed Strike: $22.32 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 3

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,500 shares

Expires 2025-12-31

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F4 · derivative.exercise_date: The canceled option was granted on January 1, 2016 and provided for vesting as to 50% of the shares underlying the option on November 9, 2016, and vesting as to the remaining 50% of the shares underlying the option on November 9, 2017.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 11,166 Not disclosed Strike: $25.56 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,166 shares

Expires 2025-11-08

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F3 · derivative.exercise_date: The canceled option was granted on November 9, 2015 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date, and vesting as to the remaining 50% of the shares underlying the option on the second anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC Verastem, Inc. VSTM · Entity 5242 Disposition to issuerStock Option (right to buy) · Derivative 12,064 Not disclosed Strike: $110.28 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,064 shares

Expires 2025-01-08

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F2 · derivative.exercise_date: The canceled option was granted on January 8, 2015 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

Read SEC document
December 19, 2023 Filed Dec 20, 2023 21:01 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 183 $7.73 $1,414.59
Disclosure

SEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,916

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 18, 2023 Filed Dec 20, 2023 21:01 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 244 $7.64 $1,864.16
Disclosure

SEC source: 0001104659-23-127724 · tm2333364-2_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,099

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 19, 2023 Filed Sep 20, 2023 20:15 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 183 $9.84 $1,800.72
Disclosure

SEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,343

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 18, 2023 Filed Sep 20, 2023 20:15 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 240 $9.91 $2,378.40
Disclosure

SEC source: 0001104659-23-102300 · tm2326467-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,526

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:40 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $10.44 $0.00
Disclosure

SEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · derivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-08-02

F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of August 2, 2023 (the "Option Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Option Grant Date until the fourth anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
August 02, 2023 Filed Aug 4, 2023 20:40 UTC Verastem, Inc. VSTM · Entity 5242 GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-23-087889 · tm2322904-1_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,766

F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of August 2, 2023 (the "RSU Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the RSU Grant Date until the fourth anniversary of the RSU Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:25 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 183 $10.30 $1,884.90
Disclosure

SEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,766

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 16, 2023 Filed Jun 21, 2023 20:25 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 244 $9.92 $2,420.48
Disclosure

SEC source: 0001104659-23-073369 · tm2319280-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,949

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 20, 2023 Filed Mar 20, 2023 20:57 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 2,339 $0.43 $1,005.77
Disclosure

SEC source: 0001104659-23-034510 · tm239927-2_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 458,351

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 16, 2023 Filed Mar 20, 2023 20:57 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 3,138 $0.40 $1,255.20
Disclosure

SEC source: 0001104659-23-034510 · tm239927-2_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 460,690

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 21:06 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 1,680,880 $0.00 Strike: $0.66 $0.00
Disclosure

SEC source: 0001104659-23-008593 · tm234891-2_4seq1.xml · derivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,680,880

Underlying: Common Stock · 1,680,880 shares

Expires 2033-01-27

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of January 27, 2023 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
December 19, 2022 Filed Dec 20, 2022 21:10 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 2,954 $0.37 $1,092.98
Disclosure

SEC source: 0001104659-22-128644 · tm2233121-3_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 463,828

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 16, 2022 Filed Dec 20, 2022 21:10 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 15,676 $0.40 $6,270.40
Disclosure

SEC source: 0001104659-22-128644 · tm2233121-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 466,782

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
September 19, 2022 Filed Sep 21, 2022 20:07 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 2,786 $1.13 $3,148.18
Disclosure

SEC source: 0001104659-22-101925 · tm2226273-2_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482,458

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
June 21, 2022 Filed Jun 22, 2022 20:06 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 2,701 $1.14 $3,079.14
Disclosure

SEC source: 0001104659-22-073486 · tm2219034-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485,244

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
May 16, 2022 Filed May 17, 2022 20:09 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 4,988 $1.03 $5,137.64
Disclosure

SEC source: 0001104659-22-061939 · tm2215781-3_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 487,945

F2 · shares: - The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
May 14, 2022 Filed May 17, 2022 20:09 UTC Verastem, Inc. VSTM · Entity 5242 GrantCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-22-061939 · tm2215781-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 492,933

F1 · shares: - Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on June 24, 2021 under the Issuer's 2021 Equity Incentive Plan. Each PRSU represents the right to receive one share of Common Stock. On May 14, 2022 the Compensation Committee of the Issuer's Board of Directors certified that the PRSUs' performance criteria had been satisfied and the PRSUs vested in full.

Read SEC document
March 21, 2022 Filed Mar 23, 2022 20:02 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 2,818 $1.27 $3,578.86
Disclosure

SEC source: 0001104659-22-037009 · tm2210137-2_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 477,933

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
January 03, 2022 Filed Jan 5, 2022 21:01 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 23,534 $2.05 $48,244.70
Disclosure

SEC source: 0001104659-22-001447 · tm221611-1_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 480,751

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 20, 2021 Filed Dec 22, 2021 21:01 UTC Verastem, Inc. VSTM · Entity 5242 SaleCommon Stock 10,994 $2.27 $24,956.38
Disclosure

SEC source: 0001104659-21-152597 · tm2136040-2_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 504,285

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 21:02 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 368,500 $0.00 Strike: $2.36 $0.00
Disclosure

SEC source: 0001104659-21-151116 · tm2135712-3_4seq1.xml · derivative · entry 4

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 368,500

Underlying: Common Stock · 368,500 shares

Expires 2031-12-15

F5 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of December 15, 2021 (the "Option Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Option Grant Date until the fourth anniversary of the Option Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
December 15, 2021 Filed Dec 17, 2021 21:02 UTC Verastem, Inc. VSTM · Entity 5242 GrantCommon Stock 181,500 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-151116 · tm2135712-3_4seq1.xml · nonDerivative · entry 3

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 515,279

F4 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of December 15, 2021 (the "RSU Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the RSU Grant Date until the fourth anniversary of the RSU Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
August 12, 2021 Filed Dec 17, 2021 21:02 UTC Verastem, Inc. VSTM · Entity 5242 Tax withholdingCommon Stock 50,244 $2.87 $144,200.28
Disclosure

SEC source: 0001104659-21-151116 · tm2135712-3_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 333,779

F1 · balance_after: The total reflects the disposition of 50,244 shares sold by the Issuer to satisfy statutory withholding requirements and an additional reduction of 46,442 shares previously withheld by the Issuer to satisfy statutory withholding requirements, in each case upon vesting of restricted stock units and a reduction of 128,684 shares transferred to the Paterson 1996 Living Trust. The total also reflects 3,333 shares purchased under the Issuer's Employee Stock Purchase Plan.

Read SEC document
December 18, 2020 Filed Dec 22, 2020 18:26 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 407,552 $0.00 Strike: $2.20 $0.00
Disclosure

SEC source: 0000904454-20-000828 · edgar.xml · derivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 407,552

Underlying: Common Stock · 407,552 shares

Expires 2030-12-18

F2 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of December 18, 2020 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
December 18, 2020 Filed Dec 22, 2020 18:26 UTC Verastem, Inc. VSTM · Entity 5242 GrantCommon Stock 135,851 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000828 · edgar.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 555,816

F1 · shares: Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2012 Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 25% of the RSUs on the first anniversary of December 18, 2020 (the "Grant Date") and as to an additional 6.25% of the RSUs at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
August 11, 2020 Filed Aug 13, 2020 15:58 UTC Verastem, Inc. VSTM · Entity 5242 GrantCommon Stock 321,679 $0.00 $0.00
Disclosure

SEC source: 0000904454-20-000566 · edgar.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,965

F1 · shares: Represents restricted stock units granted to the Reporting Person under the Issuer's Amended and Restated 2012 Incentive Plan. Each restricted stock unit represents the contingent right to receive one share of Common Stock. The restricted stock units vest 50% on December 31, 2020 and 50% on August 11, 2021, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
March 27, 2020 Filed Mar 31, 2020 00:59 UTC Verastem, Inc. VSTM · Entity 5242 GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-040697 · a4.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,286

F1 · shares: Represents restricted stock units granted to the Reporting Person under the Issuer's Amended and Restated 2012 Incentive Plan on March 27, 2020. Each restricted stock unit represents the contingent right to receive one share of Common Stock. The restricted stock units vest as to 100% of the shares on December 31, 2021, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on such vesting date.

Read SEC document
December 13, 2019 Filed Dec 18, 2019 00:39 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $1.34 $0.00
Disclosure

SEC source: 0001104659-19-073506 · a4.xml · derivative · entry 2

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2029-12-13

F2 · derivative.exercise_date: The option vests as to 50% of the shares on the first anniversary of Grant Date and as to an additional 12.5% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
December 13, 2019 Filed Dec 18, 2019 00:39 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 150,000 $0.00 Strike: $1.34 $0.00
Disclosure

SEC source: 0001104659-19-073506 · a4.xml · derivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2029-12-13

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of December 13, 2019 (the "Grant Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
June 21, 2019 Filed Jun 26, 2019 01:52 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 250,000 $0.00 Strike: $1.81 $0.00
Disclosure

SEC source: 0001104659-19-037508 · a4.xml · derivative · entry 1

Paterson Dan · CIK 0001563202 · President and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2029-06-21

F1 · derivative.exercise_date: The option vests as to 50% of the shares on the first anniversary of the date of grant and as to an additional 12.5% of the shares at the end of each successive three-month period following the first anniversary of the date of grant, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 21:52 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $3.51 $0.00
Disclosure

SEC source: 0000904454-19-000030 · edgar.xml · derivative · entry 2

Paterson Dan · CIK 0001563202 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2029-01-03

F2 · derivative.exercise_date: The option vests as to: (a) 40% of the shares upon the date on which the closing price per share of the common stock is at least $10.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, (b) 40% of the shares shall vest upon the date on which the closing price per share of the common stock is at least $15.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, and (c) 20% of the shares shall vest upon the date on which the closing price per share of the common stock is at least $20.00 on at least 20 (whether or not consecutive) of the prior 30 trading days, provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
January 03, 2019 Filed Jan 7, 2019 21:52 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 75,000 $0.00 Strike: $3.51 $0.00
Disclosure

SEC source: 0000904454-19-000030 · edgar.xml · derivative · entry 1

Paterson Dan · CIK 0001563202 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2029-01-03

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of January 1, 2019 (the "Commencement Date") and as to an additional 6.25% of the shares at the end of each successive three-month period following the first anniversary of the Commencement Date until the fourth anniversary of the Commencement Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date.

Read SEC document
September 28, 2018 Filed Oct 2, 2018 22:58 UTC Verastem, Inc. VSTM · Entity 5242 PurchaseCommon Stock 3,000 $7.00 $21,000.00
Disclosure

SEC source: 0000904454-18-000631 · edgar.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,286

Read SEC document
September 27, 2018 Filed Oct 1, 2018 22:35 UTC Verastem, Inc. VSTM · Entity 5242 PurchaseCommon Stock 1,200 $7.04 $8,448.00
Disclosure

SEC source: 0000904454-18-000611 · edgar.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,286

Read SEC document
September 27, 2018 Filed Oct 1, 2018 22:35 UTC Verastem, Inc. VSTM · Entity 5242 PurchaseCommon Stock 800 $7.01 $5,608.00
Disclosure

SEC source: 0000904454-18-000611 · edgar.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,086

Read SEC document
September 24, 2018 Filed Oct 2, 2018 22:58 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 30,000 $0.00 Strike: $2.97 $0.00
Disclosure

SEC source: 0000904454-18-000631 · edgar.xml · derivative · entry 3

Paterson Dan · CIK 0001563202 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2028-01-05

F2 · shares: On January 5, 2018, the Reporting Person was granted an option to purchase 75,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 15,000 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 30,000 shares.

Read SEC document
April 06, 2018 Filed Jun 4, 2018 21:57 UTC Verastem, Inc. VSTM · Entity 5242 GrantStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $2.97 $0.00
Disclosure

SEC source: 0001104659-18-038057 · a4.xml · derivative · entry 1

Paterson Dan · CIK 0001563202 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2028-01-05

F1 · balance_after: On January 5, 2018, the Reporting Person was granted an option to purchase 75,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 15,000 shares.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.